Roche this week said that it has certified NewGene to provide sequence capture services on its microarray and sequencing platforms.
As a certified service provider, Newcastle, UK-based NewGene will provide services for NimbleGen sequence capture arrays with next-generation sequencing on the Genome Sequencer FLX System from Roche's 454 Life Sciences business.
NewGene is the first UK-based services provider to join the Roche NimbleGen CSP network. The molecular diagnostics and research services firm is a partnership between the Newcastle Hospitals National Health System Foundation Trust and Newcastle University.
CEO David Huntley said in a statement that the ability to offer sequence capture services will "provide significant scientific, technical, and economic benefits to our UK customers."
In addition to NewGene, Berlin-based Atlas Biolabs and Ebersberg, Germany-based Eurofins MWG Operon are certified to offer NimbleGen sequence capture services in Europe and Aliso Viejo, Calif.-based Ambry Genetics is certified to offer them in North America.
Financial details of the deal with NewGene were not discussed.